| ERVK-6 |
|
endogenous retrovirus group K member 6, envelope
|
|
|
0.521 |
0.808 |
| MIR146A |
|
microRNA 146a
|
|
|
0.398 |
0.885 |
| MIR155 |
|
microRNA 155
|
|
|
0.384 |
0.885 |
| MIR21 |
|
microRNA 21
|
|
|
0.363 |
0.846 |
| ERVK-20 |
|
endogenous retrovirus group K member 20
|
|
|
0.533 |
0.692 |
| MTCO2P12 |
|
MT-CO2 pseudogene 12
|
|
|
0.368 |
0.962 |
| PIK3CD |
O00329
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
|
Kinase
|
1.00 |
0.319 |
0.885 |
| XPO1 |
O14980
|
exportin 1
|
Receptor
|
1.00 |
0.504 |
0.692 |
| SLC22A2 |
O15244
|
solute carrier family 22 member 2
|
Transporter
|
2.0E-12 |
0.572 |
0.769 |
| FOXO3 |
O43524
|
forkhead box O3
|
|
0.99 |
0.431 |
0.808 |
| DDX58 |
O95786
|
DExD/H-box helicase 58
|
|
1.8E-23 |
0.526 |
0.808 |
| COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
| MYC |
P01106
|
MYC proto-oncogene, bHLH transcription factor
|
Transcription factor
|
1.00 |
0.344 |
0.923 |
| KRAS |
P01116
|
KRAS proto-oncogene, GTPase
|
Enzyme modulator
|
7.9E-04 |
0.320 |
0.923 |
| TGFB1 |
P01137
|
transforming growth factor beta 1
|
Signaling
|
3.7E-02 |
0.287 |
0.962 |
| TNF |
P01375
|
tumor necrosis factor
|
Signaling
|
0.80 |
0.231 |
0.962 |
| IFNB1 |
P01574
|
interferon beta 1
|
|
|
0.421 |
0.846 |
| IFNG |
P01579
|
interferon gamma
|
|
0.47 |
0.288 |
0.962 |
| IL1A |
P01583
|
interleukin 1 alpha
|
|
1.6E-04 |
0.333 |
0.962 |
| IL1B |
P01584
|
interleukin 1 beta
|
|
0.13 |
0.276 |
0.962 |
| HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
| HLA-DQA1 |
P01909
|
major histocompatibility complex, class II, DQ alpha 1
|
Immune response
|
2.4E-02 |
0.416 |
0.846 |
| HLA-DRB1 |
P01911
|
major histocompatibility complex, class II, DR beta 1
|
Immune response
|
1.1E-03 |
0.333 |
0.923 |
| CXCL10 |
P02778
|
C-X-C motif chemokine ligand 10
|
Signaling
|
0.37 |
0.378 |
0.885 |
| HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |